SPY304.32+1.35 0.45%
DIA254.29-0.06 -0.02%
IXIC9,489.87+120.88 1.29%

Wedbush Maintains Outperform on Viela Bio, Raises Price Target to $63

Wedbush maintains Viela Bio (NASDAQ:VIE) with a Outperform and raises the price target from $62 to $63.

Benzinga · 05/14/2020 12:46

Wedbush maintains Viela Bio (NASDAQ:VIE) with a Outperform and raises the price target from $62 to $63.